Dominguez C, Romero E, Graciano J, Fernandez JL, Viola L. Prevalence and risk factors of acute-on-chronic liver failure in a single center from Argentina. World J Hepatol 2016; 8(34): 1529-1534 [PMID: 28008344 DOI: 10.4254/wjh.v8.i34.1529]
Corresponding Author of This Article
Cristian Dominguez, MD, Centro Integral de Gastroenterología, Ecuador 1481 PB, Capital Federal, Buenos Aires C1425EUG, Argentina. cristian.dom@hotmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Prospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hepatol. Dec 8, 2016; 8(34): 1529-1534 Published online Dec 8, 2016. doi: 10.4254/wjh.v8.i34.1529
Table 1 Chronic liver failure-sequential organ failure assessment score
Organ/system
0
1
2
3
4
Liver (bilirubin, mg/dL)
< 1.2
≥ 1.2 to ≤ 2
≥ 2 to < 6
≥ 6 to < 12
≥ 12
Kidney (creatinine, mg/dL)
< 1.2
≥ 1.2 to < 2
≥ 2 to < 3.5
≥ 3.5 to < 5 or dialysis
≥ 5 or diálysis
Cerebral (HE grade)
No HE
I
II
III
IV
Coagulation (RIN, platelet count)
< 1.1
≥ 1.1 to < 1.25
≥ 1.25 to < 1.5
≥ 1.5 to < 2.5
≥ 2.5 or platelet count ≤ 20000 per cubic millimeter
Circulation (mean arterial pressure, mmHg), inotropic drugs (μg/kg per minute)
≥ 70
< 70
Dopamine ≤ 5 or dobutamine or terlipressin
Dopamine > 5 or E ≤ 0.1 or NE ≤ 0.1
Dopamine > 15 or E > 0.1 or NE > 0.1
Lungs (SpO2/FiO2)
> 512
> 357 a ≤ 512
> 214 a ≤ 357
> 89 to ≤ 214
≤ 89
Table 2 Cirrhosis etiology
Etiology
n (%)
Alcohol
58 (58)
Alcohol + hepatitis C virus
5 (5)
Hepatitis C virus
13 (13)
Nonalcoholic steatohepatitis
4 (4)
Cryptogenic
12 (12)
Autoimmune hepatitis
4 (4)
Primary biliary cirrosis
1 (1)
Primary biliary cirrhosis + autoimmune hepatitis
1 (1)
Hepatitis B virus + alcohol
1 (1)
Hemochromatosis
1 (1)
Table 3 Prevalence of acute on chronic liver failure n (%)
ACLF
Grade 1
Grade 2
Grade 3
Patients
10 (34.4)
5 (17.3)
14 (48.3)
Mortality
3 (30)
2 (40)
13 (92)
Table 4 Type and number of organ failure n (%)
Organs failure
ACLF 1
ACLF 2
ACLF 3
Renal
7 (70)
2 (40)
10 (71)
Cerebral
1 (10)
1 (20)
12 (85)
Coagulation
1 (10)
3 (60)
8 (57)
Liver
1 (10)
1 (20)
2 (14)
Circulatory
0 (0)
1 (20)
14 (100)
Respiratory
1 (10)
2 (40)
14 (100)
Table 5 Precipitating events of acute-on-chronic liver failure
Potential precipitating events of ACLF
n (%)
Bacterial infection
12 (41.3)
Gastrointestinal hemorrhage
8 (27.5)
Renal failure secondary to acute diarrhea
1 (3.4)
No precipitating event
8 (27.5)
Table 6 Comparative results between groups with and without acute on chronic liver failure n (%)
ACLF
No ACLF
P vaule
OR
95%CI
Age (yr ± SD)
60 ± 11
60 ± 11
1.00
Male
23 (79)
44 (62)
0.11
2.3
0.78-7.43
Child Pugh (score ± DS)
10.2 ± 2.1
8.4 ± 1.6
< 0.0001
MELD (score ± DS)
20.7 ± 8.5
12.3 ± 4
< 0.0001
Active alcoholism
9 (31)
22 (31)
1.00
1
0.3-2.8
Prior ascites
18 (62)
29 (41)
0.07
2.3
0.9-6.3
Prior encephalopthy, n (%)
9 (31)
10 (14)
0.08
2.74
0.9-8.7
Esophageal varices
18 (62)
37 (52)
0.38
1.5
0.5-4
Ascites
27 (93)
43 (60.5)
0.001
8.8
1.8-58.1
Variceal hemorrhage
4 (13.7)
10 (14)
1
0.97
0.2-3.8
White cell count (n/mm3± SD)
15.300 ± 10.770
8.033 ± 5.601
< 0.0001
Serum sodium (mEq/L ± SD)
133.3 ± 6.9
135.1 ± 5.3
0.16
CRP (mg/L ± SD)
50.9 ± 46.4
28.6 ± 23.4
0.002
Mortality
18 (62)
4 (5.6)
< 0.0001
Citation: Dominguez C, Romero E, Graciano J, Fernandez JL, Viola L. Prevalence and risk factors of acute-on-chronic liver failure in a single center from Argentina. World J Hepatol 2016; 8(34): 1529-1534